Vimarsana
Biggest News Aggregation in the World

Page 3 - Turn Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Turn Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Turn Bio Today - Breaking & Trending Today

T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness - Vimarsana News

T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness

/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today presents...

Vittorio Sebastiano, Head of Turn Biotechnologies Research, to Present at Prestigious Cold Spring Harbor Laboratories - Vimarsana News

Vittorio Sebastiano, Head of Turn Biotechnologies Research, to Present at Prestigious Cold Spring Harbor Laboratories

/PRNewswire/ -- Turn Biotechnologies Co-founder and Head of Research Vittorio Sebastiano today will present at the Mechanisms of Aging Meeting taking place at...

Turn Biotechnologies lanza la plataforma de entrega eTurna™ - Vimarsana News

Turn Biotechnologies lanza la plataforma de entrega eTurna™

/PRNewswire/ -- Turn Biotechnologies, una empresa de rejuvenecimiento celular que desarrolla nuevos medicamentos de ARNm para curar afecciones intratables...

Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics - Vimarsana News

Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics

The proprietary platform is versatile, equally effective with different cargoes, routes of administration

Prominent ophthalmologist will guide Turn Bio's search for therapies to cure eye diseases - Vimarsana News

Prominent ophthalmologist will guide Turn Bio's search for therapies to cure eye diseases

Albert Wu, MD, PhD, a recognized advocate of using stem cell therapy to treat eye conditions, will advise company's development of ocular tissue